Janus Henderson Group PLC Trims Stock Holdings in Guardian Pharmacy Services, Inc. $GRDN

Key Points

• Janus Henderson Group cut its Guardian Pharmacy Services stake by 72.1% in the first quarter, selling 33,674 shares and retaining 13,000 shares valued at approximately $490,000.
• Guardian Pharmacy Services reported quarterly EPS of $0.29, exceeding estimates of $0.26, while revenue of $351.77 million also surpassed the $340.45 million consensus forecast.
• Despite the recent 6.3% trading decline, analysts maintain a generally positive outlook: the stock has a “Moderate Buy” consensus rating and an average price target of $43.83.

Janus Henderson Group PLC decreased its position in Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) by 72.1% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 13,000 shares of the company's stock after selling 33,674 shares during the quarter. Janus Henderson Group PLC's holdings in Guardian Pharmacy Services were worth $490,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in GRDN. Raymond James Financial Inc. bought a new stake in shares of Guardian Pharmacy Services during the 2nd quarter valued at $43,000. Ameritas Investment Partners Inc. increased its stake in shares of Guardian Pharmacy Services by 26.5% in the 3rd quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company's stock worth $43,000 after acquiring an additional 345 shares in the last quarter. State of Wyoming purchased a new position in Guardian Pharmacy Services during the 2nd quarter valued at about $58,000. Strs Ohio purchased a new position in shares of Guardian Pharmacy Services during the fourth quarter valued at approximately $75,000. Finally, Clearstead Advisors LLC lifted its holdings in shares of Guardian Pharmacy Services by 196.3% during the fourth quarter. Clearstead Advisors LLC now owns 2,628 shares of the company's stock valued at $79,000 after purchasing an additional 1,741 shares during the last quarter.

Guardian Pharmacy Services Trading Down 6.3%

Guardian Pharmacy Services stock opened at $41.06 on Tuesday. Guardian Pharmacy Services, Inc. has a 12 month low of $19.30 and a 12 month high of $47.02. The stock has a fifty day simple moving average of $40.96 and a two-hundred day simple moving average of $37.25. The firm has a market cap of $2.04 billion, a price-to-earnings ratio of 39.86, a PEG ratio of 2.87 and a beta of 0.11.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.29 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.26 by $0.03. Guardian Pharmacy Services had a return on equity of 29.97% and a net margin of 4.50%.The firm had revenue of $351.77 million for the quarter, compared to the consensus estimate of $340.45 million. On average, equities research analysts forecast that Guardian Pharmacy Services, Inc. will post 1.18 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

GRDN has been the topic of several recent research reports. Zacks Research downgraded Guardian Pharmacy Services from a "strong-buy" rating to a "hold" rating in a research note on Monday, May 11th. Oppenheimer lifted their price objective on Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an "outperform" rating in a research note on Friday. Wall Street Zen raised Guardian Pharmacy Services from a "hold" rating to a "buy" rating in a report on Sunday. Weiss Ratings raised Guardian Pharmacy Services from a "hold (c)" rating to a "hold (c+)" rating in a research note on Thursday. Finally, Truist Financial raised their price target on Guardian Pharmacy Services from $43.00 to $47.00 and gave the company a "buy" rating in a report on Wednesday, June 17th. Seven investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, Guardian Pharmacy Services currently has a consensus rating of "Moderate Buy" and a consensus price target of $43.83.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source